enGene Therapeutics (ENGN) EPS (Basic) (2023 - 2026)
enGene Therapeutics (ENGN) posted quarterly EPS (Basic) of -$0.43 for Q2 2026, up 14.32% year-over-year from -$0.38 in Q2 2025, and up 1.99% quarter-over-quarter from -$0.44 in Q1 2026.
enGene Therapeutics (ENGN) EPS (Basic) (2023 - 2026) Analysis & Trends
enGene Therapeutics (ENGN) has reported EPS (Basic) for 4 consecutive years, with -$0.43 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) rose 14.32% year-over-year to -$0.43; the TTM figure through Apr 2026 stood at -$1.82 (down 16.2% YoY), while the FY2025 annual figure was -$2.29, down 57.23% from the prior year.
- EPS (Basic) climbed to -$0.43 in Q2 2026 per ENGN's latest filing, from -$0.44 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.32 in Q3 2024 and bottomed at -$119.11 in Q4 2023.
- Historically, EPS (Basic) has averaged -$10.68 across 4 years, with a median of -$0.49 in 2025.
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 99.66% — and 2025, when it slumped 83.0%.
- enGene Therapeutics' EPS (Basic) stood at -$119.11 in 2023, then jumped by 99.66% to -$0.4 in 2024, then slumped by 83.0% to -$0.74 in 2025, then soared by 41.5% to -$0.43 in 2026.
- Business Quant data shows ENGN's EPS (Basic) at -$0.43 in Q2 2026, -$0.44 in Q1 2026, and -$0.74 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | enGene Therapeutics | 124.11 Mn | 124.11 Mn | - | -0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -0.43 |
| Jan 31, 2026 | -0.44 |
| Oct 31, 2025 | -0.74 |
| Jul 31, 2025 | -0.57 |
| Apr 30, 2025 | -0.51 |
| Jan 31, 2025 | -0.48 |
| Oct 31, 2024 | -0.40 |
| Jul 31, 2024 | -0.32 |
| Apr 30, 2024 | -0.38 |
| Jan 31, 2024 | -0.46 |
| Oct 31, 2023 | -119.11 |
| Jul 31, 2023 | -6.73 |
| Apr 30, 2023 | -7.61 |
| Jan 31, 2023 | -11.39 |